Long-acting opioids were associated with a greater than 2-fold risk for unintentional overdose compared with short-acting formulations, according to a cohort study published online February 16 in JAMA Internal Medicine.
Moreover, the risk was more than 5-fold greater in the first 2 weeks of using a long-acting opioid. Read more.*
*You can create a free account at Medscape to view this article.